Lyra Therapeutics Inc (LYRA) — Financial Flexibility Index
Lyra Therapeutics Inc (LYRA) has a Financial Flexibility Index of -0.13x as of December 2025. Free cash flow of $-5.97 Million (operating CF $-6.07 Million minus capex $96.00K) represents 0% of total liabilities ($46.83 Million). Also explore Lyra Therapeutics Inc (LYRA) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lyra Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Lyra Therapeutics Inc across 8 annual periods. Check Lyra Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Lyra Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Lyra Therapeutics Inc. For the full company profile including market capitalisation, see LYRA company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.61x | $-28.74 Million | $-28.86 Million | $46.83 Million | ▲ +50.3% |
| 2024 | -1.24x | $-67.67 Million | $-70.01 Million | $54.75 Million | ▼ -5.6% |
| 2023 | -1.17x | $-62.26 Million | $-63.30 Million | $53.18 Million | ▲ +20.9% |
| 2022 | -1.48x | $-43.22 Million | $-43.38 Million | $29.21 Million | ▼ -35.5% |
| 2021 | -1.09x | $-22.43 Million | $-25.82 Million | $20.55 Million | ▲ +64.3% |
| 2020 | -3.06x | $-19.37 Million | $-21.14 Million | $6.34 Million | ▼ -72.3% |
| 2019 | -1.77x | $-13.54 Million | $-13.75 Million | $7.63 Million | ▼ -3457.6% |
| 2018 | -0.05x | $-6.60 Million | $-6.64 Million | $132.43 Million | — |